Authors' reply
[...]the review includes a report that sulpiride seemed to cause problems with increased prolactin levels and galactorrhoea. 5 Claims that the drug shows particular efficacy against negative symptoms were not supported by trial data. [...]any evidence that sulpiride is a particularly atypical typica...
Saved in:
Published in | British journal of psychiatry Vol. 201; no. 3; pp. 247 - 248 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Cambridge University Press
01.09.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...]the review includes a report that sulpiride seemed to cause problems with increased prolactin levels and galactorrhoea. 5 Claims that the drug shows particular efficacy against negative symptoms were not supported by trial data. [...]any evidence that sulpiride is a particularly atypical typical antipsychotic is, at best, not strong. Declaration ofinterest In the past 3 years, S.W.L. hasreceived advisory board fees from Janssen-Cilag and speaker fees fromAstraZeneca; T.R.E.B. has spoken at an event sponsored by Lilly; P.B.J.is a member of a scientific advisory board for Roche, and has receivedresearch support from GlaxoSmithKline and a speaker fee fromLilly. 1 Peluso MJ, Lewis SW, Barnes TRE, Jones PB. First– vs second–generation antipsychotic drugs inschizophrenia - reply. |
---|---|
ISSN: | 0007-1250 1472-1465 |
DOI: | 10.1192/bjp.201.3.247a |